Clinuvel Pharma

NICE Refuses to Fund Rare Disease Drug Despite Pleas

NICE is adamant about rejecting a medicine for a rare condition

SG Tylor

The UK’s National Institute for Health and Care Excellence (NICE) has issued its final verdict on Clinuvel’s Scenesse, a treatment ...